Pascal Soriot, the CEO of AstraZeneca, was paid £17.7 million in 2025. There is a possibility that in 2026 he will earn approximately £20 million.
Radu Burcă
Current Affairs
Foto: profimedia.com
Always see our news on Google
AstraZeneca announced that its CEO, Pascal Soriot, earned £17.7 million in 2025, an increase of over 6% compared to 2024, when he earned £16.6 million. This includes annual bonuses of £4.3 million and long-term shares worth £11.6 million. The company reported a profit increase of 40% and a rise in shares over the last 12 months, and Soriot could benefit from an additional salary increase in 2026, with a possible maximum package of £19.6 million. Although AstraZeneca is expanding its operations in the US and China and investing in weight loss drugs, it has reduced investments in the UK, canceling a £450 million expansion for a vaccine facility last year. Soriot has consistently been named the highest-paid CEO in the UK, earning 176 times the average salary of an AstraZeneca employee.
Sources
Latest News
21:23
A1 will be closed between Cisnădie and Boița / Traffic will be diverted onto DN7 and DN1
21:13
Siegfried Mureșan claims that some PSD parliamentarians are dissatisfied with Grindeanu's leadership
21:04
A Canadian farmer who moved to Russia to escape “woke” ideology risks being sent to the front in Ukraine
20:47
Otokar signed a $1.472 billion export contract for wheeled armored vehicles without disclosing the client
20:30
South Africa recorded 43 deaths in attacks with an alleged political connection ahead of the local elections on November 4
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
Current Affairs
Who are the highest-paid bosses at state-owned companies in Romania? One director earns over 134,000 lei per month from three positions
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
